Cart
0

Pulmonary Devices Market by Type (Therapeutic Devices, Consumables & Accessories, Diagnostic Devices, and Monitoring Devices), by Disease (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, and Infectious Diseases), and by End User (Hospitals, Ambulatory Care, and Home Care) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_184188
Pages: NA
Jan 2019 | 465 Views
 
Author's : NA
Tables: NA
Charts: NA
 

Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract.

Factors such as increase in prevalence of respiratory diseases, rise in geriatric population, sedentary lifestyle, high prevalence of smoking, growth in pollution levels, and urbanization drive the market growth. However, reimbursement issues and harmful effects of certain respiratory care devices on neonates restrain the market growth. Moreover, rise in need for home care therapeutic devices and healthcare growth in the developing countries increase opportunities for the market growth.

The global pulmonary devices market is segmented on the basis of type, disease, end user, and region. On the basis of type, it is segmented into therapeutic devices, consumables & accessories, diagnostic devices, and monitoring devices. By therapeutic devices, it is classified into humidifiers (heated and passover humidifiers), nebulizers, oxygen concentrators (fixed and portable oxygen concentrators), positive airway pressure (PAP) devices (continuous PAP devices, automatic PAP devices, and bi-level PAP devices), reusable resuscitators (adult resuscitators and infant/neonatal resuscitators), ventilators (adult ventilators and neonatal ventilators), inhalers (metered dose inhalers and dry powder inhalers), masks (nasal masks, full-face masks, nasal pillow masks, and oral masks), nitric oxide delivery units, and oxygen hoods. The consumables and accessories segment is sub segmented into disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas, and others. The diagnostic devices segment is sub segmented into spirometers, polysomnography devices (PSG), peak flow meters, and other diagnostic devices. The monitoring devices segment is sub segmented into pulse oximeters (pulse oximeter sensors and pulse oximeter equipment), capnographs, and gas analyzers. On the basis of disease, the market is categorized into asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, infectious diseases, and others. On the basis of end-user, it is divided into hospitals, ambulatory care, and home care. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Some of the prominent players in the global market include GlaxoSmithKline plc, 3M Company, Medtronic plc, Koninklijke Philips N.V., ResMed Inc., Masimo Corporation, Thermo Fisher Scientific, Fisher & Paykel Healthcare Limited, Becton, Dickinson and Company, and Hamilton Medical AG.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product helps understand the various types of devices used for treatment of pulmonary diseases.
  • Comprehensive analysis of all geographical regions is provided, which helps determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.

Pulmonary Devices Market Key Segments:

By Type

  • Therapeutic Devices
    • Humidifiers
      • Heated Humidifiers
      • Passover Humidifiers
    • Oxygen Concentrators
      • Fixed Oxygen Concentrators
      • Portable Oxygen Concentrators
    • Positive Airway Pressure (PAP) Devices
      • Continuous PAP Devices
      • Automatic PAP Devices
      • Bi-level PAP Devices
    • Reusable Resuscitators
      • Adult Resuscitators
      • Infant/Neonatal Resuscitators
    • Ventilators
      • Adult Ventilators
      • Neonatal Ventilators
    • Masks
      • Nasal Masks
      • Full-face Masks
      • Nasal Pillow Masks
      • Oral Masks
    • Inhalers
      • Metered Dose Inhalers
      • Dry Powder Inhalers
    • Nebulizers
    • Nitric Oxide Delivery Units Oxygen Hoods
  • Consumables and Accessories
    • Disposable Masks
    • Disposable Resuscitators
    • Tracheostomy Tubes
    • Nasal Cannulas
    • Others
  • Diagnostic Devices
    • Spirometer
    • Peak Flow meters
    • Polysomnography Devices
    • Others
  • Monitoring Devices
    • Pulse Oximeters
      • Pulse Oximeter Sensors
      • Pulse Oximeter Equipment
    • Capnographs
    • Gas Analyzers

By Disease

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Sleep Apnea
  • Infectious Diseases
  • Others

By End User

  • Hospitals
  • Ambulatory Care
  • Home Care

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 GLOBAL PULMONARY DEVICES MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. THERAPEUTIC DEVICES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Humidifiers

4.2.4.1. Market size and forecast
4.2.4.2. Heated Humidifiers 

4.2.4.2.1. Market size and forecast

4.2.4.3. Passover Humidifiers

4.2.4.3.1. Market size and forecast

4.2.5. Oxygen Concentrators

4.2.5.1. Market size and forecast
4.2.5.2. Fixed oxygen concentrators

4.2.5.2.1. Market size and forecast

4.2.5.3. Portable oxygen concentrators

4.2.5.3.1. Market size and forecast

4.2.6. Positive Airway Pressure (PAP) Devices

4.2.6.1. Market size and forecast
4.2.6.2. Continuous PAP Devices 

4.2.6.2.1. Market size and forecast

4.2.6.3. Automatic PAP Devices

4.2.6.3.1. Market size and forecast

4.2.6.4. Bi-level PAP Devices

4.2.6.4.1. Market size and forecast

4.2.7. Reusable Resuscitators

4.2.7.1. Market size and forecast
4.2.7.2. Market size and forecast
4.2.7.3. Adult Resuscitators

4.2.7.3.1. Market size and forecast

4.2.7.4. Infant/Neonatal Resuscitators

4.2.7.4.1. Market size and forecast

4.2.8. Ventilators

4.2.8.1. Market size and forecast
4.2.8.2. Adult Ventilators 

4.2.8.2.1. Market size and forecast

4.2.8.3. Neonatal Ventilators

4.2.8.3.1. Market size and forecast

4.2.9. Masks

4.2.9.1. Market size and forecast
4.2.9.2. Nasal Masks

4.2.9.2.1. Market size and forecast

4.2.9.3. Full-face Masks 

4.2.9.3.1. Market size and forecast

4.2.9.4. Nasal Pillow Masks

4.2.9.4.1. Market size and forecast

4.2.9.5. Oral Masks

4.2.9.5.1. Market size and forecast

4.2.10. Inhalers

4.2.10.1. Market size and forecast
4.2.10.2. Metered Dose Inhalers 

4.2.10.2.1. Market size and forecast

4.2.10.3. Dry Powder Inhalers

4.2.10.3.1. Market size and forecast

4.2.11. Nebulizers

4.2.11.1. Market size and forecast

4.2.12. Nitric Oxide Delivery Units

4.2.12.1. Market size and forecast

4.2.13. Oxygen Hoods

4.2.13.1. Market size and forecast

4.3. CONSUMABLES & ACCESSORIES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Disposable Masks

4.3.4.1. Market size and forecast

4.3.5. Disposable Resuscitators 

4.3.5.1. Market size and forecast

4.3.6. Tracheostomy Tubes 

4.3.6.1. Market size and forecast

4.3.7. Nasal Cannulas 

4.3.7.1. Market size and forecast

4.3.8. Others

4.3.8.1. Market size and forecast

4.4. DIAGNOSTIC DEVICES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Spirometer

4.4.4.1. Market size and forecast

4.4.5. Peak Flow Meters 

4.4.5.1. Market size and forecast

4.4.6. Polysomnography Devices 

4.4.6.1. Market size and forecast

4.4.7. Others

4.4.7.1. Market size and forecast

4.5. MONITORING DEVICES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Pulse Oximeters 

4.5.4.1. Market size and forecast
4.5.4.2. Pulse Oximeter Sensors

4.5.4.2.1. Market size and forecast

4.5.4.3. Pulse Oximeter Equipment

4.5.4.3.1. Market size and forecast

4.5.5. Capnographs 

4.5.5.1. Market size and forecast

4.5.6. Gas Analyzers

4.5.6.1. Market size and forecast

Chapter: 5 GLOBAL PULMONARY DEVICES MARKET, BY DISEASE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ASTHMA

5.2.1. Market size and forecast

5.3. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

5.3.1. Market size and forecast

5.4. SLEEP APNEA

5.4.1. Market size and forecast

5.5. INFECTIOUS DISEASE

5.5.1. Market size and forecast

5.6. OTHERS

5.6.1. Market size and forecast

Chapter: 6 GLOBAL PULMONARY DEVICES MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY CARE

6.3.1. Market size and forecast

6.4. HOME CARE

6.4.1. Market size and forecast

Chapter: 7 GLOBAL PULMONARY DEVICES MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America Pulmonary DevicesMarket, by Type
7.2.5. North America Pulmonary Devices Market, by Disease
7.2.6. North America Pulmonary Devices Market, by End User

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.3.4. Europe Pulmonary Devices Market, by Type
7.3.5. Europe Pulmonary Devices Market, by Disease
7.3.6. Europe Pulmonary Devices Market, by End User

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific Pulmonary Devices Market, by Type
7.4.5. Asia-Pacific Pulmonary Devices Market, by Disease
7.4.6. Asia-Pacific Pulmonary Devices Market, by End User

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Saudi Arabia market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

7.5.4. LAMEA Pulmonary Devices Market, by Type
7.5.5. LAMEA Pulmonary Devices Market, by Disease
7.5.6. LAMEA Pulmonary Devices Market, by End User

Chapter: 8 COMPANY PROFILES

8.1. GLAXOSMITHKLINE PLC

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. 3M COMPANY

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. MEDTRONIC PLC

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. KONINKLIJKE PHILIPS N.V.

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. RESMED INC.

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. MASIMO CORPORATION

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. THERMO FISHER SCIENTIFIC

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. FISHER & PAYKEL HEALTHCARE LIMITED

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. BECTON, DICKINSON AND COMPANY

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. HAMILTON MEDICAL AG

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
Pulmonary Devices Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4565
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5160
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $6747
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo